According to ADC Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.27. In 2022 the company made an earnings per share (EPS) of -$2.01 an increase over its 2021 EPS that were of -$3.00.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.27 | 12.94% |
2022 | -$2.01 | -33% |
2021 | -$3.00 | -17.21% |
2020 | -$3.62 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -3.96% | ๐บ๐ธ USA |